Stock Quote
Spectrum Pharmaceuticals Inc (SPPI.W) (NASD ADF)
$4.72
1:27pm EST
+2.39%
$4.61
$4.72
200
$4.72
$4.72
$10.00
$1.29
1.39
1,624,253
SPPI.W
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Shrotriya, Rajesh | Chairman of the Board, President, Chief Executive Officer | 4,201,475 |
| Kumaria, Shyam | Vice President - Finance | 763,919 |
| Vida, Julius | Director | -- |
Profile
Spectrum Pharmaceuticals, Inc. ( Spectrum) is a commercial stage biopharmaceutical company, engaged in developing and commercializing therapies with a focus primarily in the areas of hematology-oncology and urology. The Company’s product is apaziquone (formerly EOquin), which is in two Phase 3... Full Description
Company Address
Spectrum Pharmaceuticals Inc
157 Technology Drive
Irvine CA 92618
P: +1949.7886700
F: +1949.7886706
157 Technology Drive
Irvine CA 92618
P: +1949.7886700
F: +1949.7886706
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Ardana plc | £6.50 | 0.00 |
| Neurocrine Biosciences, Inc. | $2.17 | +0.04 |
| Abraxis Bioscience, Inc. | $33.63 | -0.22 |
| SPPI.W | Industry | |
|---|---|---|
| P/E(TTM) | -- | 3.57 |
| P/S(TTM) | 6.55 | 0.57 |
| ROI(TTM) | -34.67 | 1.86 |
| ROE(TTM) | -39.19 | 2.51 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | -- |
| EPS Est. (Current Year) | -0.56 |
| Total Revenue | $8.14M |
| Net Income | $-9.71M |
| EPS | $-0.28 |
